Advances in Small-Cell Lung Cancer (SCLC) Translational Research-Reference-Cited by-同舟云学术

Advances in Small-Cell Lung Cancer (SCLC) Translational Research

Published:2020-06-08 Issue:4 Volume:11 Page:a038240
ISSN:2157-1422
Container-title:Cold Spring Harbor Perspectives in Medicine
language:en
Short-container-title:Cold Spring Harb Perspect Med

Author:

Drapkin Benjamin J.,Rudin Charles M.

Publisher

Cold Spring Harbor Laboratory

Subject

General Biochemistry, Genetics and Molecular Biology

Reference274 articles.

1. Results of the Two Incidence Screenings in the National Lung Screening Trial

2. SnapShot: Immune Checkpoint Inhibitors

3. Manipulation of costimulatory signals to enhance antitumor T-cell responses

4. American Cancer Society. 2020. Cancer facts & figures. The American Cancer Society, Atlanta, GA. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html.

5. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in lung cancer organoid (tumoroid) research (Review);Experimental and Therapeutic Medicine;2024-08-01

2. Nomograms Predict PFS and OS for SCLC Patients After Standardized Treatment: A Real-World Study;International Journal of General Medicine;2024-05

3. Transformation of adenocarcinoma into small cell lung cancer as one of the mechanisms of acquired resistance to anti-EGFR tyrosine kinase inhibitors;Pathologia;2024-04-22

4. Applied models and molecular characteristics of small cell lung cancer;Pathology and Oncology Research;2024-04-22

5. Establishment of a small-cell lung cancer (SCLC) mouse model using enhanced cancer stem-cell-functioning 3D SCLC spheroids;Molecular & Cellular Toxicology;2024-03-20